Search by Drug Name or NDC

    NDC 45802-0053-02 Betamethasone Valerate 1.2 mg/g Details

    Betamethasone Valerate 1.2 mg/g

    Betamethasone Valerate is a TOPICAL AEROSOL, FOAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is BETAMETHASONE VALERATE.

    Product Information

    NDC 45802-0053
    Product ID 45802-053_bc56ee3f-ab35-46a1-8127-f3929766a6a8
    Associated GPIs 90550020103920
    GCN Sequence Number 026471
    GCN Sequence Number Description betamethasone valerate FOAM 0.12 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 32052
    HICL Sequence Number 002883
    HICL Sequence Number Description BETAMETHASONE VALERATE
    Brand/Generic Generic
    Proprietary Name Betamethasone Valerate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Betamethasone Valerate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form AEROSOL, FOAM
    Route TOPICAL
    Active Ingredient Strength 1.2
    Active Ingredient Units mg/g
    Substance Name BETAMETHASONE VALERATE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078337
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0053-02 (45802005302)

    NDC Package Code 45802-053-02
    Billing NDC 45802005302
    Package 1 CAN in 1 CARTON (45802-053-02) / 100 g in 1 CAN
    Marketing Start Date 2013-01-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.99064
    Pricing Unit GM
    Effective Date 2022-05-18
    NDC Description BETAMETHASONE VALER 0.12% FOAM
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis